INDEPTH Network
  • Contact Us
  • Login


    • Central Data Catalog

    Citations

    Sort results by Author(s) DESC Date Title
    1 Crameri, Andreas, Jutta Marfurt, Kefas Mugittu, Nicolas Maire, Attila Regös, Jean Yves Coppee, Odile Sismeiro, Richard Burki, Eric Huber, Daniel Laubscher, Odile Puijalon, Blaise Genton, Ingrid Felger, and Hans-Peter Beck. "Rapid microarray-based method for monitoring of all currently known single-nucleotide polymorphisms associated with parasite resistance to antimalaria drugs." J. Clin. Microbiol. (2007).
    2 Joseph, Deokary, Abdunoor M. Kabanywanyi, Ruth Hulser, Zulfiqarali Premji, Omary M. S. Minzi, and Kefas Mugittu. "Exploration of in vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in under fives in Tabora region, Tanzania." Malar J (2013).
    3 Mugittu, Kefas, Salim Abdulla, Nicole Falk, Honorati Masanja, Ingrid Felger, Hassan Mshinda, Hans-Peter Beck, and Blaise Genton. "Efficacy of sulfadoxine-pyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategies." Malar. J. (2005).
    4 Mugittu, Kefas, Martin Adjuik, Georges Snounou, Francine Ntoumi, Walter Taylor, Hassan Mshinda, Piero Olliaro, and Hans-Peter Beck. "Molecular genotyping to distinguish between recrudescents and new infections in treatment trials of Plasmodium falciparum malaria conducted in Sub-Saharan Africa: adjustment of parasitological outcomes and assessment of genotyping effectiveness." Trop. Med. Int. Health (2006).
    5 Mugittu, Kefas, Blaise Genton, Hassan Mshinda, and Hans Peter Beck. "Molecular monitoring of Plasmodium falciparum resistance to artemisinin in Tanzania." Malar. J. (2006).
    6 Mugittu, Kefas, Modesta Ndejembi, Allen Malisa, Martha Lemnge, Zulfikar Premji, Alex Mwita, Watoky Nkya, Johannes Kataraihya, Salim Abdulla, Hans-Peter Beck, and Hassan Mshinda. "Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo re." Am. J. Trop. Med. Hyg. (2004).
    7 Mugittu, Kefas, Gerardo Priotto, Jean-Paul Guthmann, James Kiguli, Martin Adjuik, Georges Snounou, Hans-Peter Beck, Hassan Mshinda, Piero L. Olliaro, and Walter R. J. Taylor. "Molecular genotyping in a malaria treatment trial in Uganda - unexpected high rate of new infections within 2 weeks after treatment." Trop. Med. Int. Health (2007).
    8 Mwingira, Felista, Gamba Nkwengulila, Sonja Schoepflin, Deborah Sumari, Hans-Peter Beck, Georges Snounou, Ingrid Felger, Piero Olliaro, and Kefas Mugittu. "Plasmodium falciparum msp1, msp2 and glurp allele frequency and diversity in sub-Saharan Africa." Malar. J. (2011).
    9 Obonyo, Charles O., Francis Ochieng, Walter R. J. Taylor, Samuel A. Ochola, Kefas Mugitu, Piero Olliaro, Feiko ter Kuile, and Aggrey J. Oloo. "Artesunate plus sulfadoxine-pyrimethamine for uncomplicated malaria in Kenyan children: a randomized, double-blind, placebo-controlled trial." Trans. R. Soc. Trop. Med. Hyg. (2003).
    10 Sirima, Sodiomon Bienvenu, Alfred B. Tiono, Amadou Konaté, Amidou Diarra, Francesco Castelli, Loretxu Pinoges, Kefas Mugittu, Walter R. J. Taylor, and Piero L. Olliaros. "Efficacy of artesunate plus chloroquine for the treatment of uncomplicated malaria in children in Burkina Faso: a double-blind, randomized, controlled trial." Trans. R. Soc. Trop. Med. Hyg. (2003).